1. Akbar AN, Terry L, Timms A, Beverley PCL, Janossy G (1988) Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol 140: 2171–2178
2. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL (1992a) CD28 interaction with B7 co-stimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J Exp Med 175: 353–360
3. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL (1992b) Involvement of CD28 in major histocompatibility complex-unrestricted cytotoxicity mediated by a human NK leukemia cell line. J Immunol 149: 1115–1123
4. Azuma M, Cayabyab M, Phillips JH, Lanier LL (1993a) Requirements for CD28-dependent T cell- mediated cytotoxicity. J Immunol 150: 2091–2101
5. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C (1993b) B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366: 76–79